Efficacy of LAMA Added to ICS in Treatment of Asthma (ELITRA)
NCT02296411
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
98
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
CHF 5259 12.5 µg + Qvar
DRUG:
CHF 5259 placebo + Qvar
Sponsor
Chiesi Farmaceutici S.p.A.